Drug Profile
Research programme: apoptotic DNA immunotherapy - type 1 diabetes mellitus - Sekris Biomedical
Alternative Names: SKRS 95Latest Information Update: 30 Aug 2023
Price :
$50
*
At a glance
- Originator SEKRIS Biomedical
- Class Diabetes mellitus vaccines; DNA vaccines
- Mechanism of Action Apoptosis stimulants; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 30 Aug 2023 Discontinued - Preclinical for Type 1 diabetes mellitus in USA (Intradermal)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Intradermal, Injection)
- 22 Feb 2016 Preclinical trials in Type-1 diabetes mellitus in USA (Intradermal)